Evidence map›Paper›PMID 34629076›Full record

ArticleBMC pediatrics2021

Chylomicron retention disease caused by a new pathogenic variant in sar1b protein: a rare case report from Syria.

Leen Jamel Doya, Lava Mohammad, Razan Omran, Alexander Ali Ibrahim, Nizar Yousef, Ali Ibrahim, Mohammad Adib Houreih

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Leen Jamel DoyaDepartment of Pediatrics, Tishreen University Hospital, Lattakia, Syria. dr.leen.doya@gmail.com.ORCID 0000-0003-0814-5135
Lava MohammadDepartment of Pediatrics, Tishreen University Hospital, Lattakia, Syria.
Razan OmranDepartment of Pediatrics, Tishreen University Hospital, Lattakia, Syria.
Alexander Ali IbrahimDepartment of Internal Medicine, Tishreen University Hospital, Lattakia, Syria.
Nizar YousefFaculty of Medicine, Tishreen University Hospital, Lattakia, Syria.
Ali IbrahimDepartment of Pediatrics, Tishreen University Hospital, Lattakia, Syria.
Mohammad Adib HoureihFaculty of Pharmacy, Al-Sham Private University, Lattakia, Syria.
Latakia University · SY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChylomicron retention disease (Anderson disease) is a result for variant of the SAR1B gene. It is a rare autosomal recessive hereditary disorder with most incidence in infant. It is characterized by lipid malabsorption syndrome with fatty, chronic diarrhea, and growth retardation. CASE PRESENTATION: We report a case of a 19-month Syrian boy who presented with vomiting, growth failure, and chronic, fatty diarrhea. Upper gastrointestinal endoscopy showed whitish appearing duodenal mucosa and small intestinal biopsies revealed steatosis of enterocytes. Genetic testing confirmed chylomicron retention disease with the first description of variant located in the fourth helix of sar1b protein. The patient is treated with nutritional supplements and fat-soluble vitamin supplementation resulting in significant improvement.

conclusionEarly endoscopy is recommended in infants with persistent vomiting and failure to thrive due to high suspicion for a disorder of hypocholesterolemia. Early diagnosis and treatment are essential to avoid serious clinical complications, especially neurological impairment.

Indexed as

HypobetalipoproteinemiasMalabsorption SyndromesMonomeric GTP-Binding ProteinsHumansInfantMaleSyriaMonomeric GTP-Binding ProteinsSAR1B protein, humanAnderson’s diseaseChylomicron retention diseaseFailure to thriveFat-soluble vitamin deficiencySteatorrhea

Identifiers

PMID34629076
PMCPMC8504087
OpenAlexW3207368235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.